Results 11 to 20 of about 14,818 (181)

Prevalence and characterization of esbl- and ampc-producing escherichia coli from cattle [PDF]

Kafkas Universitesi Veteriner Fakültesi Dergisi, 2017
In this study, it was aimed to determine the prevalence of extended spectrum β-lactamase (ESBL) and/or AmpC type β-lactamase (AmpC) producing Escherichia coli from cattle in Hatay. For this purpose, 312 rectal swabs samples were collected from apparently
ASLANTAŞ Ö, ELMACIOĞLU S, YILMAZ EŞ
doaj   +1 more source

Vonoprazan-Containing Triple Therapy Based on Clarithromycin Susceptibility May Be Definitive Treatment Strategy for Eradication of <i>Helicobacter pylori</i>. [PDF]

JGH Open
ABSTRACT Aims Helicobacter pylori (H.pylori) eradication therapy often fails to eradicate clarithromycin (CAM)‐resistant strains. Individualized therapy with proton pump inhibitors and metronidazole instead of CAM could be effective for first‐line eradication based on CAM sensitivity tests. However, on the basis of these tests, whether vonoprazan (VPZ)
Murata M, Miyamoto S, Hayashi N, Ogaya M, Kurouchi K, Asano Y, Yamazaki Y, Mori S, Yaku H, Okada H, Nakano Y, Ota Y, Yamaga Y, Iwamoto S, Ueo T.   +14 more
europepmc   +2 more sources

AmpC Disk Test for Detection of Plasmid-Mediated AmpC β-Lactamases in Enterobacteriaceae Lacking Chromosomal AmpC β-Lactamases [PDF]

Journal of Clinical Microbiology, 2005
ABSTRACT Although plasmid-mediated AmpC β-lactamases were first reported in the late 1980s, many infectious disease personnel remain unaware of their clinical importance. These enzymes are typically produced by isolates of Escherichia coli , Klebsiella spp., Proteus ...
Jennifer A, Black, Ellen Smith, Moland, Kenneth S, Thomson   +2 more
openaire   +2 more sources

Aspectos generales sobre la resistencia bacteriana de gérmenes productores de β-lactamasas tipo AMPC: una revisión narrativa

Revista de la Facultad de Ciencias de la Salud, 2022
El uso indiscriminado de antibióticos ha generado un grave problema en la salud pública debido al aumento en la resistencia bacteriana. La producción por algunos gérmenes de betalactamasas tipo AmpC forma parte de los mecanismos de resistencia bacteriana;
Cristhian Camilo Rivera-Caldon, Richard Imbachi-Imbachi, Juan Camilo Tobar-Solarte, Rosa Amalia Dueñas-Cuellar   +3 more
doaj   +1 more source

Plasmid-Determined AmpC-Type β-Lactamases [PDF]

Antimicrobial Agents and Chemotherapy, 2002
The predominant mechanism for resistance to β-lactam antibiotics in gram-negative bacteria is the synthesis of β-lactamase. To meet this challenge, β-lactams with greater β-lactamase stability, including cephalosporins, carbapenems, and monobactams, were introduced in the 1980s ...
Alain, Philippon, Guillaume, Arlet, George A, Jacoby   +2 more
openaire   +2 more sources

Identification of extended spectrum beta lactamases, AmpC and carbapenemase production among isolates of Escherichia coli in North Indian tertiary care centre

Avicenna Journal of Medicine, 2018
Introduction: Identification of Extended spectrum beta lactamases (ESBL), AmpC production and carbapenemase production among isolates of Escherichia coli, helps clinician to rationalize the choice of antibiotics.
Uma Chaudhary, Shipra Agarwal, Kausalya Raghuraman   +2 more
doaj   +1 more source

Detection of AmpC-β lactamase Enzymes by AmpC DiscTest

JMS SKIMS, 2014
Microbes have many mechanisms of unresponsiveness to antimicrobial agents that may arise in them over months or years.  Among them degradation of antibiotics by enzymes is one of the common methods of bacterial resistance particularly in Enterobacteriacea.1,2 At least 400 different types of β-lactamases from clinical isolates have been discovered ...
Bashir Ahmad Fomda, Shugufta Roohi
openaire   +2 more sources

Extended-Spectrum β-lactamase Production among Enterobacter cloacae and Enterobacter aerogenes at a Tertiary Care Center in Coastal Karnataka [PDF]

National Journal of Laboratory Medicine, 2016
Introduction: Enterobacter spp. have been increasingly isolated as nosocomial pathogens. Multi-drug resistance is more frequently noted among these pathogens. Extended spectrum beta lactamases (ESBLs) are difficult to detect in Enterobacter spp.
Shashidhar Vishwanath, Swetha PS, Sushma M, Indira Bairy, Chiranjay Mukhopadhyay   +4 more
doaj   +1 more source

Antimicrobial Activities of Piperacillin-tazobactam Plus Oxyimino-cephalosporins and Gentamicin against Extensively Drug-resistant Non-carbapenemase-producing Enterobacteriaceae Isolated from Immunocompromised Patients in a Nigerian Hospital

Mediterranean Journal of Infection, Microbes and Antimicrobials, 2022
Introduction: Antimicrobial resistance among the Enterobacteriaceae members has progressed from multi to extensively drug-resistant status, thereby limiting the treatment options for immunocompromised patients (ICPs).
Abubakar Suleiman KANKARA, Usman Aliyu DUTSINMA, Ibrahim YUSUF   +2 more
doaj   +1 more source

Preliminary Study on Phenotypic Detection of ESBL and Amp-C β-Lactamase-Producing Escherichia Coli Isolates from Slaughtered Pigs

Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca: Veterinary Medicine, 2021
The presence of extended-spectrum beta-lactamase-producing Escherichia coli in food animals is a public health concern. The aim of this study was to phenotypically detect the extended β-lactamase and AmpC β-lactamase-producing E.
Marinela TIPIȘCĂ, Andreea Paula COZMA, Dragoș ANIȚĂ, Elena IȘAN, Luanda OȘLOBANU, Adriana ANIȚĂ, Gheorghe SAVUȚA   +6 more
doaj   +1 more source